Elevate Uranium Stock Current Liabilities
| ELVUF Stock | USD 0.18 0.05 38.46% |
Elevate Uranium fundamentals help investors to digest information that contributes to Elevate Uranium's financial success or failures. It also enables traders to predict the movement of Elevate OTC Stock. The fundamental analysis module provides a way to measure Elevate Uranium's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Elevate Uranium otc stock.
Elevate |
Elevate Uranium OTC Stock Current Liabilities Analysis
Elevate Uranium's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Elevate Uranium has a Current Liabilities of 0.0. This is 100.0% lower than that of the Energy sector and about the same as Uranium (which currently averages 0.0) industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Elevate Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elevate Uranium's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Elevate Uranium could also be used in its relative valuation, which is a method of valuing Elevate Uranium by comparing valuation metrics of similar companies.Elevate Uranium is currently under evaluation in current liabilities category among its peers.
Elevate Fundamentals
| Return On Equity | -0.41 | |||
| Return On Asset | -0.24 | |||
| Current Valuation | 59.41 M | |||
| Shares Outstanding | 275.5 M | |||
| Shares Owned By Insiders | 16.66 % | |||
| Shares Owned By Institutions | 10.13 % | |||
| Price To Book | 5.94 X | |||
| Price To Sales | 1,137 X | |||
| Revenue | 116.86 K | |||
| Gross Profit | 116.86 K | |||
| EBITDA | (5.69 M) | |||
| Net Income | (5.73 M) | |||
| Cash And Equivalents | 15.81 M | |||
| Cash Per Share | 0.06 X | |||
| Total Debt | 177.27 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 23.53 X | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (4.38 M) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 1.02 | |||
| Market Capitalization | 84.11 M | |||
| Total Asset | 19.33 M | |||
| Net Asset | 19.33 M |
About Elevate Uranium Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elevate Uranium's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elevate Uranium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elevate Uranium based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Elevate OTC Stock
Elevate Uranium financial ratios help investors to determine whether Elevate OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elevate with respect to the benefits of owning Elevate Uranium security.